BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lim P, Goh K. Review Article: Efficacy and safety of rabeprazole in treating gastroesophageal reflux disease. J Gastroenterol Hepatol 2004;19:S61-8. [DOI: 10.1111/j.1440-1746.2004.03592.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Bautista JM. The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: What is the evidence? J Gastroenterol Hepatol 2006;21:S112-4. [DOI: 10.1111/j.1440-1746.2006.04713.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Giannini EG, Savarino V, Testa R. Monitoring Cytochrome P-450 Activity During Rabeprazole Treatment in Patients with Gastresophageal Reflux Disease. Dig Dis Sci 2006;51:1602-6. [DOI: 10.1007/s10620-005-9035-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Shao F, Sun J, Wang G, Xie H, Zhu X, Zhang J. Liquid chromatographic–mass spectrometry analysis and pharmacokinetic studies of a novel rabeprazole formulation, sterile powder for injection, in dogs and rats. Biopharm Drug Dispos 2007;28:177-86. [DOI: 10.1002/bdd.543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]